FDA requires further trials for antiendotoxin monoclonal antibody products.
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D015982:Bias; D002986:Clinical Trials as Topic; D004345:Drug Industry; D006801:Humans; D014481:United States; D014486:United States Food and Drug Administration
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; C068069:nebacumab